Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study.

IF 3 2区 医学 Q1 SURGERY Aesthetic Surgery Journal Pub Date : 2024-11-15 DOI:10.1093/asj/sjae162
Farima Dalaei, Phillip J Dijkhorst, Sören Möller, Anne F Klassen, Claire E E de Vries, Lotte Poulsen, Manraj N Kaur, Jørn Bo Thomsen, Maarten Hoogbergen, Sophocles H Voineskos, Jussi P Repo, Jakub Opyrchal, Marek Adam Paul, Kay-Hendrik Busch, Annalisa Cogliandro, Michael Rose, Stefan J Cano, Andrea L Pusic, Jens A Sørensen
{"title":"Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study.","authors":"Farima Dalaei, Phillip J Dijkhorst, Sören Möller, Anne F Klassen, Claire E E de Vries, Lotte Poulsen, Manraj N Kaur, Jørn Bo Thomsen, Maarten Hoogbergen, Sophocles H Voineskos, Jussi P Repo, Jakub Opyrchal, Marek Adam Paul, Kay-Hendrik Busch, Annalisa Cogliandro, Michael Rose, Stefan J Cano, Andrea L Pusic, Jens A Sørensen","doi":"10.1093/asj/sjae162","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.</p><p><strong>Objectives: </strong>The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.</p><p><strong>Methods: </strong>Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.</p><p><strong>Results: </strong>A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.</p><p><strong>Conclusions: </strong>The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":"1317-1329"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565588/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Surgery Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/asj/sjae162","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.

Objectives: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.

Methods: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.

Results: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.

Conclusions: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.

Level of evidence: 3:

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过身体塑形手术中的最小重要差异提高 BODY-Q 评分的影响力:国际前瞻性队列研究。
背景:BODY-Q 是一种广泛使用的患者报告结果测量方法,用于全面评估接受身体塑形手术(BCS)患者的治疗效果。然而,要在临床实践中对 BODY-Q 进行有意义的解释和使用,还需要最小重要差异 (MID) 评分。MID 的定义是患者认为重要的结果测量得分的最小变化:本研究旨在确定接受 BCS 患者的 BODY-Q MID 估计值,以提高 BODY-Q 的可解释性:研究纳入了来自丹麦、芬兰、德国、意大利、荷兰和波兰的国际前瞻性队列数据。采用了两种基于分布的方法来估算MID:平均基线分数的0.2个标准差和BODY-Q分数从基线到术后3年的平均标准化反应变化:共纳入了 3,237 名参与者(平均年龄为 42.5±9.3 岁;体重指数为 28.9±4.9 kg/m2)的 12,554 次评估。在健康相关生活质量(HRQL)量表中,基线MID评分范围为1至5分,在外观量表中,基线MID评分范围为3至6分。从基线到3年随访期间,估计的MID评分在健康相关生活质量(HRQL)量表中为4到5分,在外观量表中为4到8分:建议用于解释患者的 BODY-Q 评分、评估不同 BCS 手术的治疗效果以及计算未来研究的样本量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
20.70%
发文量
309
审稿时长
6-12 weeks
期刊介绍: Aesthetic Surgery Journal is a peer-reviewed international journal focusing on scientific developments and clinical techniques in aesthetic surgery. The official publication of The Aesthetic Society, ASJ is also the official English-language journal of many major international societies of plastic, aesthetic and reconstructive surgery representing South America, Central America, Europe, Asia, and the Middle East. It is also the official journal of the British Association of Aesthetic Plastic Surgeons, the Canadian Society for Aesthetic Plastic Surgery and The Rhinoplasty Society.
期刊最新文献
Pectoralis Major Muscle 3D Volumetric Reconstruction in the Tuberous Breast: Anatomical and Radiomics Differences With Potential Surgical Impact. NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials. Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar Lines. IL-9 Is a Biomarker of BIA-ALCL Detected Rapidly by Lateral Flow Assay. Long-term Implications of Cosmetic Breast Surgeries on Subsequent Breast Reconstruction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1